Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Kinkade

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Trends in Immunology|June 30, 2006
The DARC conspiracy--virus invasion tacticsApril Kinkade, Carl F Ware
The Journal of Experimental Medicine|May 9, 2007
Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glandsIan R Humphreys, Carl de Trez, April Kinkade, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Synthesis and Anti-Hepatitis B Activities of 3'-Fluoro-2'-Substituted ApionucleosidesMartin Holan, Kathryn Tucker, Natalia Dyatkina, et al.
Antiviral Research|April 17, 2017
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogsZhinan Jin, April Kinkade, Ishani Behera, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessMichel Perron, Kirsten Stray, April Kinkade, et al.
Journal of Medicinal Chemistry|April 28, 2016
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) AnaloguesGuangyi Wang, Jinqiao Wan, Yujian Hu, et al.
International Journal of Molecular Sciences|November 25, 2023
Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy ModelsAndreas Jekle, Santosh Kumar Thatikonda, Ruchika Jaisinghani, et al.
Journal of Medicinal Chemistry|January 10, 2015
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge studyRichard L Mackman, Michael Sangi, David Sperandio, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Trends in Immunology|June 30, 2006
The DARC conspiracy--virus invasion tacticsApril Kinkade, Carl F Ware
The Journal of Experimental Medicine|May 9, 2007
Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glandsIan R Humphreys, Carl de Trez, April Kinkade, et al.
Molecules (Basel, Switzerland)|April 23, 2022
Synthesis and Anti-Hepatitis B Activities of 3'-Fluoro-2'-Substituted ApionucleosidesMartin Holan, Kathryn Tucker, Natalia Dyatkina, et al.
Antiviral Research|April 17, 2017
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogsZhinan Jin, April Kinkade, Ishani Behera, et al.
Antimicrobial Agents and Chemotherapy|December 16, 2015
GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessMichel Perron, Kirsten Stray, April Kinkade, et al.
Journal of Medicinal Chemistry|April 28, 2016
Synthesis and Anti-Influenza Activity of Pyridine, Pyridazine, and Pyrimidine C-Nucleosides as Favipiravir (T-705) AnaloguesGuangyi Wang, Jinqiao Wan, Yujian Hu, et al.
International Journal of Molecular Sciences|November 25, 2023
Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy ModelsAndreas Jekle, Santosh Kumar Thatikonda, Ruchika Jaisinghani, et al.
Journal of Medicinal Chemistry|January 10, 2015
Discovery of an oral respiratory syncytial virus (RSV) fusion inhibitor (GS-5806) and clinical proof of concept in a human RSV challenge studyRichard L Mackman, Michael Sangi, David Sperandio, et al.
Pageof 1